Predicting sudden cardiac death risk in heart muscle disease
Part of Heart & circulation clinical trials.
This study looks at how the heart's electrical signals can predict sudden cardiac arrest in people with a weakened heart muscle. It may help doctors identify who is at highest risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a weakened heart muscle (cardiomyopathy) with a pumping ability between 35% and 50% and at least one other risk factor for sudden cardiac death.
- Or, if your pumping ability is 35% or less, you must have a cardiac resynchronization device (a special pacemaker).
- You cannot have an implanted defibrillator (ICD) already.
- You must not be taking any heart rhythm drugs except beta-blockers or amiodarone.
- You must be at least 18 years old and under 80.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the heart's electrical signals can help doctors understand if treatments prevent dangerous heart rhythms in active people. It involves people with or without heart devices like ICDs or pacemakers, and may help improve care for active individuals with heart conditions.
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
This study helps doctors identify which heart attack survivors with moderate heart weakness are at highest risk of sudden cardiac death. Researchers will collect health information and heart imaging over 5 years to find early warning signs.
This trial studies whether implanting a defibrillator (ICD) soon after a heart attack can lower the risk of sudden cardiac death in people with weaker heart pumping and symptoms of heart failure. It compares strategies around defibrillator implantation, aiming to improve safety and outcomes.
This trial tests whether a programmed heart rhythm test can better identify who needs an implanted defibrillator (ICD) soon after a heart attack. It may help prevent dangerous fast heart rhythms (tachyarrhythmias) by guiding who gets an ICD.
This study compares modern heart failure medications and implantable cardioverter-defibrillators (ICDs) to reduce the risk of sudden cardiac death in people with a specific type of heart muscle disease (non-ischemic cardiomyopathy) that is not caused by blocked arteries. It may help guide treatment decisions for those with a weakened heart and certain scarring on heart MRI.
Hear when a new Ventricular Arrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.